Public disclosure ledger
Congress trades, connected to people and prices.
Filter the source ledger, open a member profile, inspect the ticker, and see how the market moved after the reported transaction date.
Matching disclosures
4,592
records in the current view
Linked members
49
politician profiles represented
Ticker coverage
883
unique stock symbols
Reported purchases
2,108
purchase-labeled transactions
Source records
Latest matching disclosures
| Date | Member | Ticker ▼ | Action | Disclosed range | Asset / owner | Since trade | Source |
|---|---|---|---|---|---|---|---|
| Dec. 19, 2023 senate | Shelley Moore Capito Spouse | ACN | SALE (PARTIAL) | $1,001 - $15,000 | Accenture PlcSpouse | ▲ +31.22% | Open ↗ |
| Sep. 24, 2025 senate | Markwayne Mullin Joint | ACN | SALE (FULL) | $15,001 - $50,000 | Accenture PlcJoint | ▲ +31.22% | Open ↗ |
| Feb. 15, 2023 senate | Thomas R. Carper Spouse | ABYIX | SALE (PARTIAL) | $1,001 - $15,000 | Abbey Capital Futures Strategy Fund- Class I ShaSpouse | — | Open ↗ |
| May. 10, 2022 senate | Thomas R. Carper Spouse | ABYIX | PURCHASE | $1,001 - $15,000 | Abbey Capital Futures Strategy Fund- Class I ShaSpouse | — | Open ↗ |
| May. 16, 2022 senate | Thomas R. Carper Spouse | ABYIX | PURCHASE | $1,001 - $15,000 | Abbey Capital Futures Strategy Fund- Class I ShaSpouse | — | Open ↗ |
| Jan. 17, 2024 senate | Thomas R. Carper Spouse | ABT | SALE (PARTIAL) | $1,001 - $15,000 | Abbott LaboratoriesSpouse | ▲ +16.40% | Open ↗ |
| Dec. 11, 2024 senate | Markwayne Mullin Joint | ABT | SALE (PARTIAL) | $15,001 - $50,000 | Abbott Laboratories Common StockJoint | ▲ +16.40% | Open ↗ |
| Sep. 13, 2023 senate | Markwayne Mullin Joint | ABT | PURCHASE | $15,001 - $50,000 | Abbott Laboratories Common StockJoint | ▲ +16.40% | Open ↗ |
| Feb. 24, 2025 senate | Shelley Moore Capito Spouse | ABT | SALE (PARTIAL) | $1,001 - $15,000 | Abbott LaboratoriesSpouse | ▲ +16.40% | Open ↗ |
| Oct. 17, 2022 senate | Thomas R. Carper Spouse | ABT | PURCHASE | $1,001 - $15,000 | Abbott Laboratories Common StockSpouse | ▲ +16.40% | Open ↗ |
| Oct. 3, 2023 senate | Markwayne Mullin Joint | ABT | PURCHASE | $1,001 - $15,000 | Abbott Laboratories Common StockJoint | ▲ +16.40% | Open ↗ |
| Jan. 8, 2025 senate | Markwayne Mullin Joint | ABT | SALE (FULL) | $1,001 - $15,000 | Abbott LaboratoriesJoint | ▲ +16.40% | Open ↗ |
| Jan. 13, 2022 senate | Tommy Tuberville Joint | ABQCX | SALE (FULL) | $15,001 - $50,000 | Ab Bond Fund Inc. - Ab Total Return Bond PortfoJoint | — | Open ↗ |
| Aug. 26, 2024 senate | Tommy Tuberville Self | ABNFX | PURCHASE | $50,001 - $100,000 | The Bond Fd of America Class F-2 Shares Company: AMERICAN BOND FUND OF AMERICA CL F2Self | — | Open ↗ |
| Aug. 1, 2022 senate | Tommy Tuberville Self | ABNFX | PURCHASE | $15,001 - $50,000 | The Bond Fd of America Class F-2 SharesSelf | — | Open ↗ |
| Jan. 21, 2022 senate | Tommy Tuberville Joint | ABC | SALE (FULL) | $15,001 - $50,000 | AmerisourceBergen Corporation Common StockJoint | — | Open ↗ |
| Jan. 21, 2022 senate | Tommy Tuberville Joint | ABBV | SALE (FULL) | $1,001 - $15,000 | AbbVie Inc. Common StockJoint | ▲ +24.69% | Open ↗ |
| Jan. 18, 2022 senate | Thomas R. Carper Spouse | ABBV | SALE (PARTIAL) | $1,001 - $15,000 | AbbVie Inc. Common StockSpouse | ▲ +24.69% | Open ↗ |
| Aug. 22, 2025 senate | John Boozman Joint | ABBV | SALE | $1,001 - $15,000 | AbbVie IncJoint | ▲ +24.69% | Open ↗ |
| Oct. 17, 2023 senate | Tommy Tuberville Joint | ABBV | PURCHASE | $1,001 - $15,000 | AbbVie Inc. Common StockJoint | ▲ +24.69% | Open ↗ |
| Aug. 11, 2025 senate | John Boozman Joint | ABBV | SALE | $1,001 - $15,000 | AbbVie IncJoint | ▲ +24.69% | Open ↗ |
| Apr. 3, 2023 senate | Tommy Tuberville Joint | ABBV | SALE (PARTIAL) | $1,001 - $15,000 | AbbVie Inc. Common StockJoint | ▲ +24.69% | Open ↗ |
| Jan. 19, 2024 senate | Tommy Tuberville Joint | ABBV | SALE (FULL) | $1,001 - $15,000 | AbbVie Inc. Common StockJoint | ▲ +24.69% | Open ↗ |
| Apr. 3, 2023 senate | Tommy Tuberville Joint | ABBV | SALE (PARTIAL) | $1,001 - $15,000 | AbbVie Inc. Common StockJoint | ▲ +24.69% | Open ↗ |
| Apr. 3, 2024 senate | Tommy Tuberville Joint | ABBV | PURCHASE | $1,001 - $15,000 | AbbVie Inc. Common StockJoint | ▲ +24.69% | Open ↗ |
| Nov. 20, 2023 senate | Tommy Tuberville Joint | ABBV | SALE (FULL) | $1,001 - $15,000 | Abbvie IncJoint | ▲ +24.69% | Open ↗ |
| Aug. 11, 2025 senate | John Boozman Joint | ABBV | SALE (PARTIAL) | $1,001 - $15,000 | Abbvie IncJoint | ▲ +24.69% | Open ↗ |
| Aug. 22, 2025 senate | John Boozman Joint | ABBV | SALE (PARTIAL) | $1,001 - $15,000 | Abbvie IncJoint | ▲ +24.69% | Open ↗ |
| Mar. 30, 2022 senate | Tommy Tuberville Joint | ABBV | PURCHASE | $1,001 - $15,000 | AbbVie Inc. Common StockJoint | ▲ +24.69% | Open ↗ |
| Nov. 6, 2025 senate | John Boozman Joint | AAXJ | SALE (FULL) | $1,001 - $15,000 | iShares MSCI All Country Asia ex Japan ETFJoint | ▲ +17.18% | Open ↗ |
Price changes are research context, not copy-trading returns.